These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19065973)

  • 1. Intravitreal triamcinolone acetonide injections in the treatment of retinal vein occlusions.
    Roth DB; Cukras C; Radhakrishnan R; Feuer WJ; Yarian DL; Green SN; Wheatley HM; Prenner J
    Ophthalmic Surg Lasers Imaging; 2008; 39(6):446-54. PubMed ID: 19065973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
    Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM
    Retina; 2005; 25(7):846-50. PubMed ID: 16205562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
    Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
    Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitrectomy alone versus vitrectomy with simultaneous intravitreal injection of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Uemura A; Yamamoto S; Sato E; Sugawara T; Mitamura Y; Mizunoya S
    Ophthalmic Surg Lasers Imaging; 2009; 40(1):6-12. PubMed ID: 19205489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion.
    Ozkiris A; Evereklioglu C; Erkiliç K; Ilhan O
    Eur J Ophthalmol; 2005; 15(1):96-101. PubMed ID: 15751246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
    Williamson TH; O'Donnell A
    Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.
    Cekiç O; Chang S; Tseng JJ; Barile GR; Del Priore LV; Weissman H; Schiff WM; Ober MD
    Retina; 2005; 25(7):851-5. PubMed ID: 16205563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion.
    Bashshur ZF; Ma'luf RN; Allam S; Jurdi FA; Haddad RS; Noureddin BN
    Arch Ophthalmol; 2004 Aug; 122(8):1137-40. PubMed ID: 15302653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
    Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
    Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
    Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
    J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
    Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O
    Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC; Wu WC; Chen KJ
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders.
    Tewari HK; Sony P; Chawla R; Garg SP; Venkatesh P
    Eur J Ophthalmol; 2005; 15(5):619-26. PubMed ID: 16167293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
    Park CH; Jaffe GJ; Fekrat S
    Am J Ophthalmol; 2003 Sep; 136(3):419-25. PubMed ID: 12967793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
    Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
    Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
    Jonas JB; Kreissig I; Degenring RF
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):782-3. PubMed ID: 12271378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.